StoxGud Sign in

Jagsonpal Pharmaceuticals Limited share price & analysis

NSE: JAGSNPHARM · Unclassified · as of 06 Nov 2026

₹213.21-3.04%
Market cap₹1,408 Cr
P/E—
Industry P/E19.1
P/B5.85
ROE—
Debt / equity0.00
Dividend yield—
EPS (TTM)—
52W high₹243.97
52W low₹161.07
Net margin—
Operating margin—

Returns

1 month-9.4%
6 months-0.4%
1 year-4.1%
3Y CAGR+10.0%
5Y CAGR+25.2%
10Y CAGR+30.0%
From 52W high-12.6%

Technical indicators

50-day avg₹228.88
200-day avg₹208.86
RSI (14)45
Avg volume (20D)74,672

StoxGud checklist: Neutral setup · 4/10

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

About Jagsonpal Pharmaceuticals Limited stock

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares closed at ₹213.21 on 06 Nov 2026, down 3.04% on the day. Over the past year the stock has lost 4.1%, and it is trading 12.6% below its 52-week high of ₹243.97. The price is above its 200-day moving average of ₹208.86, with a 14-day RSI of 45. On StoxGud's 10-point checklist it scores 4/10, a neutral setup.

Unclassified peers

CompanyPriceMarket capP/E1Y
Avantel Limited₹138.69₹36,86,04,549 Cr—-22.1%
Ducol Organics And Colours Limited₹120.00₹19,55,275 Cr—-25.9%
Jio Platforms Limited₹1,406.40₹12,57,181 Cr——
SBI Funds Management Limited₹499.55₹1,01,750 Cr——
Tamilnadu Telecommunication Limited₹9.93₹91,314 Cr—-21.1%
Manipal Health Enterprises Limited₹646.70₹76,294 Cr——

FAQs

What is the share price of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) closed at ₹213.21 on NSE on 06 Nov 2026.

What is the 52-week high and low of Jagsonpal Pharmaceuticals Limited?

The 52-week high is ₹243.97 and the 52-week low is ₹161.07.

What is the market cap of Jagsonpal Pharmaceuticals Limited?

The market capitalisation of Jagsonpal Pharmaceuticals Limited is ₹1,408 Cr.